Le Lézard
Classified in: Business
Subject: STH

Canadian Investment Regulatory Organization Trading Halt - KUT


VANCOUVER, BC, Feb. 7, 2025 /CNW/ - The following issues have been halted by CIRO

Company: Redishred Capital Corp.

TSX-Venture Symbol: KUT

All Issues: Yes

Reason: Pending News

Halt Time (ET): 8:41 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) ? Halts/Resumptions


These press releases may also interest you

at 07:20
Brompton Announces the Launch of Canada's First Split Corp. Class A Share ETF
Brompton Funds Limited (the "Manager") is pleased to announce that Brompton Split Corp. Class A Share ETF ("CLSA") will commence trading on the Toronto Stock Exchange (the "TSX") today. A final prospectus dated March 14, 2025 has been filed with the...

at 07:10
Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
Brii Biosciences Limited ("Brii Bio," or the "Company," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health across diseases with high unmet medical needs provided a corporate update today and reported its...

at 07:08
Bitget Celebrates 1.5 million Downloads in February
Bitget, the leading cryptocurrency exchange and Web3 company, proudly announces its position as the third most downloaded crypto exchange app worldwide in February 2025, according to data from SensorTower. With 1.57 million downloads, the platform...

at 07:05
Dentalcorp Reports Fourth Quarter and Full Year 2024 Results, Declares Inaugural Dividend
dentalcorp Holdings Ltd. ("Dentalcorp" or the "Company") , Canada's largest and one of North America's fastest growing networks of dental practices, today announced its financial and operating results for the fourth quarter and full year ended...

at 07:05
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2024 Results on March 26, 2025
Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies, including gene elimination, gene insertion, and gene excision programs, today announced...

at 07:00
OTC Markets Group Welcomes NIGHTINGALE HEALTH OYJ to OTCQX
OTC Markets Group Inc. , operator of regulated markets for trading 12,000 U.S. and international securities, today announced NIGHTINGALE HEALTH OYJ , a company focused on preventative healthcare, has qualified to trade on the OTCQX® Best Market....

More news about Business...


News published on and distributed by: